Overview

HLA Typing Market is poised to register a CAGR of 5.9% during the forecast period 2022 to 2028.

Increased insistence for diagnostic products, increased private-public collaboration for extensive HLA research, rising prevalence of infectious diseases and soaring number of transplant processes are some of the crucial factors responsible for the growth of the market. HLA class I and II antigen identification is performed by the procedure of molecular diagnostics that is based on DNA. These novel innovations of the DNA are being utilised by the HLA typing that provide more accurate, vigorous results that rely on identifying the differences in HLA genes. Furthermore, advancements in technology, rise in the number of processes that involve stem cell transplantation, soft tissue transplantation and solid organ transplantation, bolstering support in R&D, escalating public and private funds are some of the other driving factors responsible for the HLA typing market growth. Additionally, the technological shift to gene-based HLA profiling from serological assays shall boost the proliferation of the market.

Market Segmentation:

By Technology
• Molecular Assay Technologies
o PCR-Based Molecular Assays
• Real-Time PCR
• Sequence-Specific Primer PCR
• Sequence Specific Oligonucleotide PCR
• Other PCR Molecular Assays
o Sequencing based Molecular Assays
• Sanger Sequencing
• Next Generation Sequencing
• Other Sequencing Based Molecular Assays
• Non-Molecular Assay Technology

By Products and Services
• Reagents and Consumables
• Instruments
• Software and Services

By Application
• Diagnostic Applications
o Donor-recipient cross-matching
o Infectious Disease Testing
o Cancer Diagnosis & Prevention
o Transfusion Therapy
o Other Diagnostic Applications
• Research Applications

By End User
• Commercial service providers
• Hospitals and Surgical Centers
• Research Laboratories and Academic Institutes

By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is fragmented into technology, products and services, application, end user and region. The technology segment is categorised into molecular assay technology and non-molecular assay technology. The molecular assay technology is divided into PCR-based molecular assays and sequencing based molecular assays. The molecular assay technology segment is predicted to hold the largest HLA typing market and this can be credited to the advantages provided by assays like high procedural efficacy, low turnaround time, real-time sample analysis and multi sample studying. The products and service segment is divided into reagents and consumables, instruments, software and services. The application segment is bifurcated into diagnostic applications and research applications. The end user segment is classified into hospitals and transplant centres, research laboratories, academic institutes and independent reference laboratories. The independent reference laboratories dominated the market, and this can be credited to the automation and rapid modernization of diagnostic labs, increased R&D activities that are outsourced by biotech and pharmaceutical companies.

Regional Analysis:

The North America region is expected to subjugate the market during the forecast period owing to advancements in the healthcare, increase in the number of organ transplantation surgeries performed and advancements in the transplant diagnostic technology.

Competitive Landscape:

Some of the major players of the market are Thermo Fisher Scientific Inc., QIAGEN N.V., Illumina, CareDx Inc., Immucor Inc., Bio-Rad Laboratories Inc., F. Hoffman-La Roche Ltd., Hologic Inc., Luminex, Biofortuna, Takara Bio, Omixon.
Thermo Fisher Scientific provide different modalities for diagnostic imaging for transplant diagnostic surgeries including HLA typing. The company has emphasized on launching new products, collaborations and agreements for sustaining their leadership position.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global HLA typing market by technology, by product and service, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com